Ribo and Insilico Medicine Partner to Advance AI Guided siRNA Drug Development
Suzhou Ribo Life Science and Insilico Medicine have announced a strategic collaboration to accelerate siRNA drug development using AI platforms, combining Ribo's RNAi expertise with Insilico's Pharma.AI technology.